--- title: "早盘趋势｜远大医药再试新低，板块利空压制主线能否触底反弹？" description: "1 月 12 日，远大医药（0512.HK）全日 8 元线反复震荡，医药板块近期成为资金流出重灾区，行情持续承压。公司无新产品申报、无外延并购等利好，短线 “真空期”。盘中偶有拉升终被空头压制，弱反弹无法打破承压格局。MACD、KDJ、布林带均走弱，底部横盘寻底氛围浓。 医药政策监管收紧，市场无重磅新药、重组等刺激。主流资金主动避险，情绪整体冷静。分析认为，政策若转宽或重大项目重启才会点燃修复行情" type: "news" locale: "zh-CN" url: "https://longbridge.com/zh-CN/news/272239459.md" published_at: "2026-01-13T01:00:00.000Z" --- # 早盘趋势｜远大医药再试新低，板块利空压制主线能否触底反弹？ > 1 月 12 日，远大医药（0512.HK）全日 8 元线反复震荡，医药板块近期成为资金流出重灾区，行情持续承压。公司无新产品申报、无外延并购等利好，短线 “真空期”。盘中偶有拉升终被空头压制，弱反弹无法打破承压格局。MACD、KDJ、布林带均走弱，底部横盘寻底氛围浓。 医药政策监管收紧，市场无重磅新药、重组等刺激。主流资金主动避险，情绪整体冷静。分析认为，政策若转宽或重大项目重启才会点燃修复行情。盘中突发并购/药品进展等为短炒信号，否则下行动能充足。 风险控制：关注行业龙头动向及政策新闻，操作上以防守为主。极端走势防资金失血下带来新一轮补跌。 1 月 12 日，远大医药（0512.HK）全日 8 元线反复震荡，医药板块近期成为资金流出重灾区，行情持续承压。公司无新产品申报、无外延并购等利好，短线 “真空期”。盘中偶有拉升终被空头压制，弱反弹无法打破承压格局。MACD、KDJ、布林带均走弱，底部横盘寻底氛围浓。 医药政策监管收紧，市场无重磅新药、重组等刺激。主流资金主动避险，情绪整体冷静。分析认为，政策若转宽或重大项目重启才会点燃修复行情。盘中突发并购/药品进展等为短炒信号，否则下行动能充足。 风险控制：关注行业龙头动向及政策新闻，操作上以防守为主。极端走势防资金失血下带来新一轮补跌。 ### Related Stocks - [00512.HK - 远大医药](https://longbridge.com/zh-CN/quote/00512.HK.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | China's Drug Regulator Puts Hengrui Pharmaceuticals' SHR-1918 Injection in Priority Review | China's Drug Regulator Puts Hengrui Pharmaceuticals' SHR-1918 Injection in Priority Review | [Link](https://longbridge.com/zh-CN/news/276838200.md) | | Sunshine Lake Pharma Wins NMPA Nod to Trial First China-Developed Nipah Virus Antibody | Sunshine Lake Pharma has received approval from China's Center for Drug Evaluation to begin clinical trials for HEC-648 | [Link](https://longbridge.com/zh-CN/news/276716153.md) | | Shanghai Fosun Pharmaceutical Units Trial Nod for Lung Cancer Drug in China | Shanghai Fosun Pharmaceutical Units Trial Nod for Lung Cancer Drug in China | [Link](https://longbridge.com/zh-CN/news/276886600.md) | | 08:53 ETTransMedia Group to Uplift Mental Health & Addiction Advocacy of TV Personality and Upcoming Author Jennifer Gaydos Hartman | TransMedia Group is set to amplify the advocacy of Jennifer Gaydos Hartman, a TV personality and author, as mental healt | [Link](https://longbridge.com/zh-CN/news/276744925.md) | | Azafaros Announces Publication of Preclinical Efficacy Data with Nizubaglustat in GM2 Gangliosidosis | Azafaros has published preclinical efficacy data for its drug, nizubaglustat, in GM2 gangliosidosis, showing significant | [Link](https://longbridge.com/zh-CN/news/276841077.md) | --- > **免责声明**：本文内容仅供参考，不构成任何投资建议。